AAAAAA
Results:
1-8
|
Results: 8
Authors:
Dreicer, R
Citation: R. Dreicer, Recent developments in chemotherapy for bladder cancer - The Vaughn/Malkowicz article reviewed, ONCOLOGY-NY, 15(6), 2001, pp. 775-776
Authors:
Dreicer, R
See, WA
Klein, EA
Citation: R. Dreicer et al., Phase II trial of GM-CSF in advanced prostate cancer, INV NEW DR, 19(3), 2001, pp. 261-265
Authors:
Dreicer, R
Klein, EA
Citation: R. Dreicer et Ea. Klein, Preliminary observations of single-agent docetaxel as neoadjuvant therapy for locally advanced prostate cancer, SEMIN ONCOL, 28(4), 2001, pp. 45-48
Authors:
Berenson, JR
Rosen, LS
Howell, A
Parter, L
Coleman, RE
Morley, W
Dreicer, R
Kuross, SA
Lipton, A
Seaman, JJ
Citation: Jr. Berenson et al., Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases - A double-blind, randomized dose-response study, CANCER, 91(7), 2001, pp. 1191-1200
Authors:
Borden, EC
Lindner, D
Dreicer, R
Hussein, M
Peereboom, D
Citation: Ec. Borden et al., Second-generation interferons for cancer: clinical targets, SEM CANC B, 10(2), 2000, pp. 125-144
Authors:
Dreicer, R
Citation: R. Dreicer, The evolving role of hormone therapy in advanced prostate cancer, CLEV CLIN J, 67(10), 2000, pp. 720
Authors:
Dreicer, R
Manola, J
Roth, BJ
Cohen, MB
Hatfield, AK
Wilding, G
Citation: R. Dreicer et al., Phase II study of cisplatin and paclitaxel in advanced carcinoma of the urothelium: An Eastern Cooperative Oncology Group study, J CL ONCOL, 18(5), 2000, pp. 1058-1061
Authors:
Dreicer, R
Smith, DC
Williams, RD
See, WA
Citation: R. Dreicer et al., Phase II trial of suramin in patients with metastatic renal cell carcinoma, INV NEW DR, 17(2), 1999, pp. 183-186
Risultati:
1-8
|